Global Clinical Trail Management System (CTMS) Market 2023-2027

Description

List of Tables

Technavio has been monitoring the clinical trail management system (CTMS) market and is forecast to grow by $1449.16 million during 2022-2027, accelerating at a CAGR of 12.81% during the forecast period. Our report on the clinical trail management system (CTMS) market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing healthcare expenditure, rise in clinical trials for drugs, and increased adoption of CTMS.

Technavio's clinical trail management system (CTMS) market is segmented as below:

By Deployment

On-premise
Cloud

By End-user

Pharmaceutical and biotechnology companies
CROs
Others

By Geographical Landscape

North America
Europe
Asia
Rest of World (ROW)

This study identifies the increasing outsourcing of clinical trial process as one of the prime reasons driving the clinical trail management system (CTMS) market growth during the next few years. Also, the integration of CTMS with other systems and the adoption of cloud computing will lead to sizable demand in the market.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on the clinical trail management system (CTMS) market covers the following areas:

Clinical trail management system (CTMS) market sizing
Clinical trail management system (CTMS) market forecast
Clinical trail management system (CTMS) market industry analysis

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading clinical trail management system (CTMS) market vendors that include ArisGlobal LLC, eResearchTechnology GmbH, Advarra Inc., Dassault Systemes SE, DATATRAK International Inc., International Business Machines Corp., Medpace Holdings Inc., Oracle Corp., Parexel International Corp., Veeva Systems Inc., Laboratory Corp. of America Holdings, DSG Inc., MasterControl Inc., Wipro Ltd., MedNet, Medfiles USA, Crucial Data Solutions Inc., Ennov SAS, RealTime Software Solutions LLC, and PHARMASEAL. Also, the clinical trail management system (CTMS) market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Product Code: IRTNTR43269

1 Executive Summary

1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Deployment
Exhibit 06: Executive Summary - Chart on Market Segmentation by End-user
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics

3 Market Sizing

3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2022
3.4 Market outlook: Forecast for 2022-2027
Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

4 Historic Market Size

4.1 Global clinical trail management system (CTMS) market 2017 - 2021
Exhibit 18: Historic Market Size - Data Table on Global clinical trail management system (CTMS) market 2017 - 2021 ($ million)
4.2 Deployment Segment Analysis 2017 - 2021
Exhibit 19: Historic Market Size - Deployment Segment 2017 - 2021 ($ million)
4.3 End-user Segment Analysis 2017 - 2021
Exhibit 20: Historic Market Size - End-user Segment 2017 - 2021 ($ million)
4.4 Geography Segment Analysis 2017 - 2021
Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
4.5 Country Segment Analysis 2017 - 2021
Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)

5 Five Forces Analysis

5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

6 Market Segmentation by Deployment

6.1 Market segments
Exhibit 30: Chart on Deployment - Market share 2022-2027 (%)
Exhibit 31: Data Table on Deployment - Market share 2022-2027 (%)
6.2 Comparison by Deployment
Exhibit 32: Chart on Comparison by Deployment
Exhibit 33: Data Table on Comparison by Deployment
6.3 On-premise - Market size and forecast 2022-2027
Exhibit 34: Chart on On-premise - Market size and forecast 2022-2027 ($ million)
Exhibit 35: Data Table on On-premise - Market size and forecast 2022-2027 ($ million)
Exhibit 36: Chart on On-premise - Year-over-year growth 2022-2027 (%)
Exhibit 37: Data Table on On-premise - Year-over-year growth 2022-2027 (%)
6.4 Cloud - Market size and forecast 2022-2027
Exhibit 38: Chart on Cloud - Market size and forecast 2022-2027 ($ million)
Exhibit 39: Data Table on Cloud - Market size and forecast 2022-2027 ($ million)
Exhibit 40: Chart on Cloud - Year-over-year growth 2022-2027 (%)
Exhibit 41: Data Table on Cloud - Year-over-year growth 2022-2027 (%)
6.5 Market opportunity by Deployment
Exhibit 42: Market opportunity by Deployment ($ million)

7 Market Segmentation by End-user

7.1 Market segments
Exhibit 43: Chart on End-user - Market share 2022-2027 (%)
Exhibit 44: Data Table on End-user - Market share 2022-2027 (%)
7.2 Comparison by End-user
Exhibit 45: Chart on Comparison by End-user
Exhibit 46: Data Table on Comparison by End-user
7.3 Pharmaceutical and biotechnology companies - Market size and forecast 2022-2027
Exhibit 47: Chart on Pharmaceutical and biotechnology companies - Market size and forecast 2022-2027 ($ million)
Exhibit 48: Data Table on Pharmaceutical and biotechnology companies - Market size and forecast 2022-2027 ($ million)
Exhibit 49: Chart on Pharmaceutical and biotechnology companies - Year-over-year growth 2022-2027 (%)
Exhibit 50: Data Table on Pharmaceutical and biotechnology companies - Year-over-year growth 2022-2027 (%)
7.4 CROs - Market size and forecast 2022-2027
Exhibit 51: Chart on CROs - Market size and forecast 2022-2027 ($ million)
Exhibit 52: Data Table on CROs - Market size and forecast 2022-2027 ($ million)
Exhibit 53: Chart on CROs - Year-over-year growth 2022-2027 (%)
Exhibit 54: Data Table on CROs - Year-over-year growth 2022-2027 (%)
7.5 Others - Market size and forecast 2022-2027
Exhibit 55: Chart on Others - Market size and forecast 2022-2027 ($ million)
Exhibit 56: Data Table on Others - Market size and forecast 2022-2027 ($ million)
Exhibit 57: Chart on Others - Year-over-year growth 2022-2027 (%)
Exhibit 58: Data Table on Others - Year-over-year growth 2022-2027 (%)
7.6 Market opportunity by End-user
Exhibit 59: Market opportunity by End-user ($ million)

8 Customer Landscape

8.1 Customer landscape overview
Exhibit 60: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

9.1 Geographic segmentation
Exhibit 61: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibit 62: Data Table on Market share By Geographical Landscape 2022-2027 (%)
9.2 Geographic comparison
Exhibit 63: Chart on Geographic comparison
Exhibit 64: Data Table on Geographic comparison
9.3 North America - Market size and forecast 2022-2027
Exhibit 65: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 66: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 67: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibit 68: Data Table on North America - Year-over-year growth 2022-2027 (%)
9.4 Europe - Market size and forecast 2022-2027
Exhibit 69: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 70: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 71: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibit 72: Data Table on Europe - Year-over-year growth 2022-2027 (%)
9.5 Asia - Market size and forecast 2022-2027
Exhibit 73: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 74: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 75: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibit 76: Data Table on Asia - Year-over-year growth 2022-2027 (%)
9.6 Rest of World (ROW) - Market size and forecast 2022-2027
Exhibit 77: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 78: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 79: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibit 80: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
9.7 US - Market size and forecast 2022-2027
Exhibit 81: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibit 82: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibit 83: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibit 84: Data Table on US - Year-over-year growth 2022-2027 (%)
9.8 China - Market size and forecast 2022-2027
Exhibit 85: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibit 86: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibit 87: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibit 88: Data Table on China - Year-over-year growth 2022-2027 (%)
9.9 Germany - Market size and forecast 2022-2027
Exhibit 89: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibit 90: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibit 91: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibit 92: Data Table on Germany - Year-over-year growth 2022-2027 (%)
9.10 Canada - Market size and forecast 2022-2027
Exhibit 93: Chart on Canada - Market size and forecast 2022-2027 ($ million)
Exhibit 94: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
Exhibit 95: Chart on Canada - Year-over-year growth 2022-2027 (%)
Exhibit 96: Data Table on Canada - Year-over-year growth 2022-2027 (%)
9.11 UK - Market size and forecast 2022-2027
Exhibit 97: Chart on UK - Market size and forecast 2022-2027 ($ million)
Exhibit 98: Data Table on UK - Market size and forecast 2022-2027 ($ million)
Exhibit 99: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibit 100: Data Table on UK - Year-over-year growth 2022-2027 (%)
9.12 Market opportunity By Geographical Landscape
Exhibit 101: Market opportunity By Geographical Landscape ($ million)

10 Drivers, Challenges, and Trends

10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 102: Impact of drivers and challenges in 2022 and 2027
10.4 Market trends

11 Vendor Landscape

11.1 Overview
11.2 Vendor landscape
Exhibit 103: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 104: Overview on factors of disruption
11.4 Industry risks
Exhibit 105: Impact of key risks on business

12 Vendor Analysis

12.1 Vendors covered
Exhibit 106: Vendors covered
12.2 Market positioning of vendors
Exhibit 107: Matrix on vendor position and classification
12.3 Advarra Inc.
Exhibit 108: Advarra Inc. - Overview
Exhibit 109: Advarra Inc. - Product / Service
Exhibit 110: Advarra Inc. - Key offerings
12.4 ArisGlobal LLC
Exhibit 111: ArisGlobal LLC - Overview
Exhibit 112: ArisGlobal LLC - Product / Service
Exhibit 113: ArisGlobal LLC - Key offerings
12.5 Dassault Systemes SE
Exhibit 114: Dassault Systemes SE - Overview
Exhibit 115: Dassault Systemes SE - Product / Service
Exhibit 116: Dassault Systemes SE - Key news
Exhibit 117: Dassault Systemes SE - Key offerings
12.6 DATATRAK International Inc.
Exhibit 118: DATATRAK International Inc. - Overview
Exhibit 119: DATATRAK International Inc. - Product / Service
Exhibit 120: DATATRAK International Inc. - Key news
Exhibit 121: DATATRAK International Inc. - Key offerings
12.7 DSG Inc.
Exhibit 122: DSG Inc. - Overview
Exhibit 123: DSG Inc. - Product / Service
Exhibit 124: DSG Inc. - Key offerings
12.8 eResearchTechnology GmbH
Exhibit 125: eResearchTechnology GmbH - Overview
Exhibit 126: eResearchTechnology GmbH - Product / Service
Exhibit 127: eResearchTechnology GmbH - Key offerings
12.9 International Business Machines Corp.
Exhibit 128: International Business Machines Corp. - Overview
Exhibit 129: International Business Machines Corp. - Business segments
Exhibit 130: International Business Machines Corp. - Key offerings
Exhibit 131: International Business Machines Corp. - Segment focus
12.10 Laboratory Corp. of America Holdings
Exhibit 132: Laboratory Corp. of America Holdings - Overview
Exhibit 133: Laboratory Corp. of America Holdings - Business segments
Exhibit 134: Laboratory Corp. of America Holdings - Key news
Exhibit 135: Laboratory Corp. of America Holdings - Key offerings
Exhibit 136: Laboratory Corp. of America Holdings - Segment focus
12.11 MasterControl Inc.
Exhibit 137: MasterControl Inc. - Overview
Exhibit 138: MasterControl Inc. - Product / Service
Exhibit 139: MasterControl Inc. - Key offerings
12.12 MedNet
Exhibit 140: MedNet - Overview
Exhibit 141: MedNet - Product / Service
Exhibit 142: MedNet - Key offerings
12.13 Medpace Holdings Inc.
Exhibit 143: Medpace Holdings Inc. - Overview
Exhibit 144: Medpace Holdings Inc. - Product / Service
Exhibit 145: Medpace Holdings Inc. - Key offerings
12.14 Oracle Corp.
Exhibit 146: Oracle Corp. - Overview
Exhibit 147: Oracle Corp. - Business segments
Exhibit 148: Oracle Corp. - Key news
Exhibit 149: Oracle Corp. - Key offerings
Exhibit 150: Oracle Corp. - Segment focus
12.15 Parexel International Corp.
Exhibit 151: Parexel International Corp. - Overview
Exhibit 152: Parexel International Corp. - Product / Service
Exhibit 153: Parexel International Corp. - Key news
Exhibit 154: Parexel International Corp. - Key offerings
12.16 Veeva Systems Inc.
Exhibit 155: Veeva Systems Inc. - Overview
Exhibit 156: Veeva Systems Inc. - Business segments
Exhibit 157: Veeva Systems Inc. - Key offerings
Exhibit 158: Veeva Systems Inc. - Segment focus
12.17 Wipro Ltd.
Exhibit 159: Wipro Ltd. - Overview
Exhibit 160: Wipro Ltd. - Business segments
Exhibit 161: Wipro Ltd. - Key news
Exhibit 162: Wipro Ltd. - Key offerings
Exhibit 163: Wipro Ltd. - Segment focus

13 Appendix

13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 164: Inclusions checklist
Exhibit 165: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 166: Currency conversion rates for US$
13.4 Research methodology
Exhibit 167: Research methodology
Exhibit 168: Validation techniques employed for market sizing
Exhibit 169: Information sources
13.5 List of abbreviations
Exhibit 170: List of abbreviations